|
|
|
FOCUS ON REGULATORY & COMPLIANCE |
|
|
|
By Cell & Gene: The Podcast | In this episode of Cell & Gene: The Podcast, Host Erin Harris talks to Halloran Consulting Group's Monika Swietlicka to discuss how the FDA is increasing flexibility in CGT development without lowering evidentiary standards, emphasizing a risk-based, holistic approach. | |
|
|
| Precision Detection Of Adapter Dimers In NGS Libraries | Application Note | Agilent Technologies | Identifying low-level adapter dimers is essential for sequencing success. Compare electrophoresis methods to see how different kits resolve small fragments and improve your quality control results. |
|
|
| Smarter Automation Strategies For Scalable Cell Therapies | Article | By Michelle Duquette, Ph.D., Invetech | By integrating automation into manufacturing workflows early, organizations can accelerate timelines, reduce resource strain, and build more reliable, scalable, and compliant production systems. |
|
|
| Unlock The Power Of Clinical Data Science | White Paper | Revvity Signals Software, Inc. | Adopt a unified approach to help clinical teams manage data complexity. Accelerate insight generation and improve trial oversight to enable faster, more informed decision-making across the board. |
|
|
|
|
|
|
|
| Navigating The Complex Regulatory World Of ATMPs/CGTs | Q&A | By Louis Cicchini, Ph.D., Michael Day, Ph.D., and Joerg Schneider, Ph.D., Cencora | Shifting definitions for ATMPs and CGTs impact global development. Stay informed on CMC validation requirements, European legislation, and the latest expedited regulatory pathways available today. |
|
|
|
| Recombinant Trypsin Frequently Asked Questions | Article | Roche CustomBiotech | Identify these key features of high-quality recombinant trypsin. This guide provides insightful answers to common questions about how this enzyme can benefit your specific bioprocessing goals. |
|
|
| Next Generation Sequencing In Viral Safety Testing | White Paper | By Victor Muthu, Ph.D., Eurofins | Next Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development. |
|
|
|
|
| Fast And Sensitive Mycoplasma Detection Workflow | Application Note | QIAGEN | Digital PCR enables fast, sensitive mycoplasma detection in cell-based products. See how this pharmacopeia-compliant workflow improves accuracy, reduces delays, and supports reliable decision-making. |
|
|
REGULATORY & COMPLIANCE SOLUTIONS |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|